Baillie Gifford - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 375 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$20,019,850
+46.4%
441,063
+81.1%
0.02%
+50.0%
Q2 2023$13,675,367
+14.8%
243,594
-7.5%
0.01%
+9.1%
Q1 2023$11,911,365
+11.3%
263,3510.0%0.01%0.0%
Q4 2022$10,705,218
-43.2%
263,351
-8.7%
0.01%
-42.1%
Q3 2022$18,857,000288,5530.02%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q1 2023
NameSharesValueWeighting ↓
Gilfoyle Management LLC 150$6,37612.96%
Versant Venture Management, LLC 498,558$22,629,54812.03%
NEA Management Company, LLC 1,587,854$72,072,6935.57%
ARK Investment Management 7,163,118$325,133,9132.49%
Nikko Asset Management Americas, Inc. 3,465,470$157,263,0291.88%
Integral Health Asset Management, LLC 275,000$12,482,2501.73%
Merlin Capital, Inc 9,092$412,6861.54%
Del-Sette Capital Management, LLC 33,977$1,542,2161.52%
Green Alpha Advisors, LLC 34,880$1,583,2031.22%
Ikarian Capital, LLC 2,039$9,255,0211.11%
View complete list of CRISPR THERAPEUTICS AG shareholders